scispace - formally typeset
J

Janice S. Chen

Researcher at University of California, Berkeley

Publications -  22
Citations -  5413

Janice S. Chen is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Cas9 & CRISPR. The author has an hindex of 14, co-authored 22 publications receiving 3118 citations. Previous affiliations of Janice S. Chen include Lawrence Berkeley National Laboratory & University of California.

Papers
More filters
Journal ArticleDOI

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity

TL;DR: It is shown that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA cleavage activity by Cas12a that completely degrades ssDNA molecules, which is also a property of other type V CRISPR-Cas12 enzymes.
Journal ArticleDOI

Enhanced proofreading governs CRISPR–Cas9 targeting accuracy

TL;DR: A new hyper-accurate Cas9 variant (HypaCas9) is designed that demonstrates high genome-wide specificity without compromising on-target activity in human cells and offers a more comprehensive model to rationalize and modify the balance between target recognition and nuclease activation for precision genome editing.
Journal ArticleDOI

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.

TL;DR: Metagenomic data show that multiple CRISPR-Cas14 systems evolved independently and suggest a potential evolutionary origin of single-effector CRISpr-based adaptive immunity, as well as a fast and high-fidelity nucleic acid detection system that enabled detection ofsingle-nucleotide polymorphisms.
Journal ArticleDOI

Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.

TL;DR: Molecular structures of the catalytically active Streptococcus pyogenes Cas9 R-loop are determined that show the displaced DNA strand located near the RuvC nuclease domain active site in a conformation essential for concerted DNA cutting.
Posted ContentDOI

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy

TL;DR: A non-catalytic domain within Cas9, REC3, recognizes target mismatches and governs the HNH nuclease to regulate overall catalytic competence, and a new hyper-accurate Cas9 variant (HypaCas9) is designed that retains robust on-target activity in human cells.